CN1309316C - 含乳酸杆菌作为活性成分的活细菌制剂以及含有乳酸杆菌的食品 - Google Patents
含乳酸杆菌作为活性成分的活细菌制剂以及含有乳酸杆菌的食品 Download PDFInfo
- Publication number
- CN1309316C CN1309316C CNB02828691XA CN02828691A CN1309316C CN 1309316 C CN1309316 C CN 1309316C CN B02828691X A CNB02828691X A CN B02828691XA CN 02828691 A CN02828691 A CN 02828691A CN 1309316 C CN1309316 C CN 1309316C
- Authority
- CN
- China
- Prior art keywords
- acidi lactici
- bacillus acidi
- saliva
- lactic acid
- bacterial strain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 105
- 238000002360 preparation method Methods 0.000 title claims abstract description 42
- 235000013305 food Nutrition 0.000 title claims abstract description 33
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract description 98
- 235000014655 lactic acid Nutrition 0.000 title abstract description 49
- 239000004310 lactic acid Substances 0.000 title abstract description 49
- 239000004615 ingredient Substances 0.000 title 1
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 196
- 208000028169 periodontal disease Diseases 0.000 claims abstract description 46
- 206010006326 Breath odour Diseases 0.000 claims abstract description 28
- 208000032139 Halitosis Diseases 0.000 claims abstract description 28
- 244000005706 microflora Species 0.000 claims abstract description 3
- 210000003296 saliva Anatomy 0.000 claims description 110
- 230000001580 bacterial effect Effects 0.000 claims description 98
- 210000000214 mouth Anatomy 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 20
- 229920001542 oligosaccharide Polymers 0.000 claims description 17
- 150000005846 sugar alcohols Chemical class 0.000 claims description 15
- 150000002482 oligosaccharides Chemical class 0.000 claims description 14
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 9
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 201000001245 periodontitis Diseases 0.000 claims description 5
- 208000007565 gingivitis Diseases 0.000 claims description 4
- 241000186869 Lactobacillus salivarius Species 0.000 claims description 3
- 230000010534 mechanism of action Effects 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 1
- 230000003211 malignant effect Effects 0.000 abstract description 25
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 230000035479 physiological effects, processes and functions Effects 0.000 abstract description 2
- 206010036790 Productive cough Diseases 0.000 abstract 1
- 230000002542 deteriorative effect Effects 0.000 abstract 1
- 210000003802 sputum Anatomy 0.000 abstract 1
- 208000024794 sputum Diseases 0.000 abstract 1
- 241000194019 Streptococcus mutans Species 0.000 description 38
- 241000605862 Porphyromonas gingivalis Species 0.000 description 34
- 229920001503 Glucan Polymers 0.000 description 28
- 238000000034 method Methods 0.000 description 23
- 229920001817 Agar Polymers 0.000 description 21
- 241000186660 Lactobacillus Species 0.000 description 20
- 239000008272 agar Substances 0.000 description 20
- 229940039696 lactobacillus Drugs 0.000 description 20
- 238000012360 testing method Methods 0.000 description 19
- 230000000694 effects Effects 0.000 description 18
- 239000000796 flavoring agent Substances 0.000 description 15
- 235000019634 flavors Nutrition 0.000 description 15
- 235000013372 meat Nutrition 0.000 description 15
- 235000014347 soups Nutrition 0.000 description 15
- 235000010419 agar Nutrition 0.000 description 14
- 239000002609 medium Substances 0.000 description 14
- 230000002265 prevention Effects 0.000 description 14
- 230000004083 survival effect Effects 0.000 description 13
- 230000001413 cellular effect Effects 0.000 description 11
- 235000009508 confectionery Nutrition 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 239000001963 growth medium Substances 0.000 description 10
- 241000282414 Homo sapiens Species 0.000 description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 9
- 239000001301 oxygen Substances 0.000 description 9
- 229910052760 oxygen Inorganic materials 0.000 description 9
- 235000015218 chewing gum Nutrition 0.000 description 8
- 229940112822 chewing gum Drugs 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 7
- 240000001046 Lactobacillus acidophilus Species 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 239000013024 dilution buffer Substances 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 238000010494 dissociation reaction Methods 0.000 description 5
- 230000005593 dissociations Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 4
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 241000194017 Streptococcus Species 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 235000015140 cultured milk Nutrition 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 238000013207 serial dilution Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- -1 sorbierite Chemical compound 0.000 description 4
- 150000003464 sulfur compounds Chemical class 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 208000007976 Ketosis Diseases 0.000 description 3
- 241000193987 Streptococcus sobrinus Species 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 239000003899 bactericide agent Substances 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000002079 cooperative effect Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 150000002584 ketoses Chemical class 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 230000008774 maternal effect Effects 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- 244000199866 Lactobacillus casei Species 0.000 description 2
- 235000013958 Lactobacillus casei Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000057717 Streptococcus lactis Species 0.000 description 2
- 235000014897 Streptococcus lactis Nutrition 0.000 description 2
- 241000194025 Streptococcus oralis Species 0.000 description 2
- 241000194020 Streptococcus thermophilus Species 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 229940017800 lactobacillus casei Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000012956 testing procedure Methods 0.000 description 2
- 229960003487 xylose Drugs 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 240000002605 Lactobacillus helveticus Species 0.000 description 1
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000269799 Perca fluviatilis Species 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 241001135221 Prevotella intermedia Species 0.000 description 1
- 241001135225 Prevotella nigrescens Species 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- NGFMICBWJRZIBI-JZRPKSSGSA-N Salicin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O1)c1c(CO)cccc1 NGFMICBWJRZIBI-JZRPKSSGSA-N 0.000 description 1
- 241000194048 Streptococcus equi Species 0.000 description 1
- 241000194049 Streptococcus equinus Species 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 208000010641 Tooth disease Diseases 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010060926 abdominal symptom Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- NGFMICBWJRZIBI-UHFFFAOYSA-N alpha-salicin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UHFFFAOYSA-N 0.000 description 1
- 229940089837 amygdalin Drugs 0.000 description 1
- YZLOSXFCSIDECK-UHFFFAOYSA-N amygdalin Natural products OCC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC(C#N)c3ccccc3 YZLOSXFCSIDECK-UHFFFAOYSA-N 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- 230000010065 bacterial adhesion Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- DLRVVLDZNNYCBX-ZZFZYMBESA-N beta-melibiose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)O1 DLRVVLDZNNYCBX-ZZFZYMBESA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- YGHHWSRCTPQFFC-UHFFFAOYSA-N eucalyptosin A Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC(C#N)C=2C=CC=CC=2)OC(CO)C(O)C1O YGHHWSRCTPQFFC-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- CEAZRRDELHUEMR-UHFFFAOYSA-N gentamicin Chemical class O1C(C(C)NC)CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N CEAZRRDELHUEMR-UHFFFAOYSA-N 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 201000011066 hemangioma Diseases 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 229940054346 lactobacillus helveticus Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000032724 odontogenesis Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000024241 parasitism Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 150000004040 pyrrolidinones Chemical class 0.000 description 1
- 238000012207 quantitative assay Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- NGFMICBWJRZIBI-UJPOAAIJSA-N salicin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1CO NGFMICBWJRZIBI-UJPOAAIJSA-N 0.000 description 1
- 229940120668 salicin Drugs 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000009291 secondary effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 235000021262 sour milk Nutrition 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229940115921 streptococcus equinus Drugs 0.000 description 1
- 229940031008 streptococcus mutans Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/366—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G4/123—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/179—Sakei
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2002/003177 WO2003082027A1 (fr) | 2002-03-29 | 2002-03-29 | Preparations cellulaires vitales et aliments contenant une bacterie lactique comme principe actif |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1625345A CN1625345A (zh) | 2005-06-08 |
CN1309316C true CN1309316C (zh) | 2007-04-11 |
Family
ID=28470406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB02828691XA Expired - Fee Related CN1309316C (zh) | 2002-03-29 | 2002-03-29 | 含乳酸杆菌作为活性成分的活细菌制剂以及含有乳酸杆菌的食品 |
Country Status (10)
Country | Link |
---|---|
US (1) | US7674613B2 (ko) |
EP (1) | EP1498039B1 (ko) |
JP (1) | JP4203855B2 (ko) |
KR (1) | KR100843020B1 (ko) |
CN (1) | CN1309316C (ko) |
AU (1) | AU2002243005A1 (ko) |
DK (1) | DK1498039T3 (ko) |
HK (1) | HK1073230A1 (ko) |
TW (1) | TW200305370A (ko) |
WO (1) | WO2003082027A1 (ko) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050281756A1 (en) * | 2004-06-14 | 2005-12-22 | Eamonn Connolly | Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
WO2006022471A1 (en) * | 2004-08-25 | 2006-03-02 | Jong Suk Oh | Lactic acid bacteria inhibiting halitosis |
US20060062773A1 (en) * | 2004-09-21 | 2006-03-23 | The Procter & Gamble Company | Compositions for maintaining and restoring normal gastrointestinal flora |
EP2133414A1 (en) | 2008-06-11 | 2009-12-16 | Basf Se | Uses and methods for preventing and /or treating oral malodour |
JP5365166B2 (ja) * | 2008-11-28 | 2013-12-11 | ライオン株式会社 | 乳酸菌を含有する口腔用組成物 |
US20110014324A1 (en) * | 2009-07-10 | 2011-01-20 | Christoffer Lundqvist | Product for the storage of freeze-dried lactic acid bacteria mixed with oral rehydration solution |
US20120128645A1 (en) | 2009-07-16 | 2012-05-24 | Hiroshima University | Prophylactic, ameliorating or therapeutic agent for oral diseases |
CN102311932B (zh) * | 2010-07-07 | 2014-03-19 | 生展生物科技股份有限公司 | 改善口腔内细菌群的唾液乳酸杆菌及其保健组合物 |
JP2012092094A (ja) * | 2010-09-30 | 2012-05-17 | Wakamoto Pharmaceutical Co Ltd | 油脂中に乳酸菌を含有する口腔用組成物 |
CN102618452B (zh) * | 2011-02-01 | 2014-06-25 | 任发政 | 唾液乳杆菌及其代谢物的制备方法和组合物以及应用 |
WO2013021957A1 (ja) | 2011-08-05 | 2013-02-14 | 株式会社ヤクルト本社 | 口腔内疾患の予防又は治療剤 |
US20160017287A1 (en) | 2013-03-04 | 2016-01-21 | Swiss Stem Cell Foundation | System for extraction of cells from a sample of tissue |
CN104825380A (zh) * | 2015-04-21 | 2015-08-12 | 溧水区人民医院 | 一种快速恢复口腔正常菌群的护理液及其制备方法 |
JP6236052B2 (ja) * | 2015-11-16 | 2017-11-22 | 欽也 斉藤 | 口内虫歯予防粉及び口内虫歯予防粉の製造方法 |
JP6480090B1 (ja) * | 2017-05-12 | 2019-03-06 | キッコーマン株式会社 | 二本鎖rna高含有乳酸菌の製造方法及び該乳酸菌 |
KR102095339B1 (ko) * | 2017-06-01 | 2020-05-27 | 한국생명공학연구원 | 신규한 락토바실러스 류테리 균주 및 이를 유효성분으로 포함하는 치주질환 예방 또는 치료용 조성물 |
CN111373463A (zh) * | 2017-11-16 | 2020-07-03 | 宝洁公司 | 产品演示装置及其方法 |
US11147845B2 (en) | 2018-07-16 | 2021-10-19 | ProBiora Health, LLC | Foods containing beneficial oral bacteria |
JP6487106B1 (ja) * | 2018-10-15 | 2019-03-20 | 株式会社湖池屋 | 免疫機能向上用食品組成物 |
JP7160652B2 (ja) * | 2018-11-29 | 2022-10-25 | 雪印メグミルク株式会社 | 歯周病予防用組成物 |
KR102001074B1 (ko) * | 2018-12-07 | 2019-07-18 | 주식회사 메디오젠 | 충치 억제 활성을 갖는 유산균 조성물 |
KR102230517B1 (ko) * | 2019-07-09 | 2021-03-22 | 주식회사 메디오젠 | 충치 억제 활성을 갖는 락토바실러스 살리바리우스를 포함하는 조성물 |
KR102210092B1 (ko) * | 2019-07-09 | 2021-02-01 | 주식회사 메디오젠 | 충치 억제 활성을 갖는 락토바실러스 루테리 mg505 를 포함하는 조성물 |
KR102649531B1 (ko) * | 2019-12-26 | 2024-03-22 | 여장욱 | 동물용 프로바이오틱스 페이스트 및 그 제조 방법 |
CN112126605A (zh) * | 2020-10-12 | 2020-12-25 | 镇江市天益生物科技有限公司 | 一种唾液乳杆菌及其应用 |
CN114053313B (zh) * | 2022-01-17 | 2022-04-01 | 中科嘉亿营养医学(山东)微生态研究院有限公司 | 一种唾液乳杆菌jyls-372在制备解酒护肝产品中的应用 |
CN115040465B (zh) * | 2022-07-06 | 2023-01-24 | 浙江爱尚日用品有限公司 | 一种有效祛除牙斑、牙垢的增白牙膏 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0154549A2 (en) * | 1984-03-09 | 1985-09-11 | Kabushiki Kaisya Advance | Anticariogenic or antiperiodontitic agent |
CN1268172A (zh) * | 1997-08-07 | 2000-09-27 | 钟淑五 | 新的乳酸菌 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6191126A (ja) | 1984-10-09 | 1986-05-09 | Advance Res & Dev Co Ltd | 抗歯周症剤 |
DE3439094A1 (de) * | 1984-10-25 | 1986-05-07 | Henkel KGaA, 4000 Düsseldorf | Mund- und zahnpflegemittel |
JPH107577A (ja) * | 1996-06-17 | 1998-01-13 | Yakult Honsha Co Ltd | 血糖降下剤 |
KR100753012B1 (ko) * | 1999-08-03 | 2007-08-30 | 가부시키가이샤 야쿠루트 혼샤 | 발효유 음식품 및 그의 제조방법 |
JP3648115B2 (ja) | 2000-01-14 | 2005-05-18 | 株式会社ヤクルト本社 | 乳酸菌の培養方法及び飲食品 |
SI1312667T1 (sl) * | 2000-08-25 | 2009-04-30 | Wakamoto Pharma Co Ltd | Probiotiäśni produkti, ki vsebujejo sev l. salivarius |
-
2002
- 2002-03-29 DK DK02708726.1T patent/DK1498039T3/da active
- 2002-03-29 CN CNB02828691XA patent/CN1309316C/zh not_active Expired - Fee Related
- 2002-03-29 US US10/508,340 patent/US7674613B2/en not_active Expired - Lifetime
- 2002-03-29 JP JP2003579579A patent/JP4203855B2/ja not_active Expired - Lifetime
- 2002-03-29 EP EP02708726A patent/EP1498039B1/en not_active Expired - Lifetime
- 2002-03-29 WO PCT/JP2002/003177 patent/WO2003082027A1/ja active Application Filing
- 2002-03-29 AU AU2002243005A patent/AU2002243005A1/en not_active Abandoned
- 2002-03-29 KR KR1020047015110A patent/KR100843020B1/ko active IP Right Grant
-
2003
- 2003-03-28 TW TW92107146A patent/TW200305370A/zh not_active IP Right Cessation
-
2005
- 2005-07-18 HK HK05106059A patent/HK1073230A1/xx not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0154549A2 (en) * | 1984-03-09 | 1985-09-11 | Kabushiki Kaisya Advance | Anticariogenic or antiperiodontitic agent |
US4746512A (en) * | 1984-03-09 | 1988-05-24 | Kabushiki Kaisya Advance Kaihatsu Kenkyujo | Anticariogenic or antiperiodontitic agent |
CN1268172A (zh) * | 1997-08-07 | 2000-09-27 | 钟淑五 | 新的乳酸菌 |
Also Published As
Publication number | Publication date |
---|---|
TWI342750B (ko) | 2011-06-01 |
WO2003082027A1 (fr) | 2003-10-09 |
KR100843020B1 (ko) | 2008-07-01 |
TW200305370A (en) | 2003-11-01 |
JPWO2003082027A1 (ja) | 2005-07-28 |
US20070071737A1 (en) | 2007-03-29 |
KR20040111434A (ko) | 2004-12-31 |
EP1498039B1 (en) | 2012-10-03 |
CN1625345A (zh) | 2005-06-08 |
DK1498039T3 (da) | 2012-10-15 |
JP4203855B2 (ja) | 2009-01-07 |
EP1498039A8 (en) | 2005-06-22 |
EP1498039A4 (en) | 2006-03-29 |
HK1073230A1 (en) | 2005-09-30 |
AU2002243005A1 (en) | 2003-10-13 |
US7674613B2 (en) | 2010-03-09 |
EP1498039A1 (en) | 2005-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1309316C (zh) | 含乳酸杆菌作为活性成分的活细菌制剂以及含有乳酸杆菌的食品 | |
US11871775B2 (en) | Method of inhibiting oral pathogens | |
CN1094972C (zh) | 人类来源的乳酸杆菌菌株、它们的组合物及其应用 | |
US7666407B2 (en) | Lactobacillus paracasei-containing product | |
CN1639318A (zh) | 抗微生物组合物 | |
JP5365166B2 (ja) | 乳酸菌を含有する口腔用組成物 | |
CN1342196A (zh) | 用于治疗炎性疾病的双歧杆菌 | |
WO2010110374A1 (ja) | 血糖降下作用増強剤 | |
CN104023732A (zh) | 口腔疾患的预防或治疗剂 | |
CN1802101A (zh) | 异麦芽酮糖醇(1,6gps和1,1gpm混合物)作为生产用于治疗肠道疾病的药物及其他用途的益生元的应用 | |
CN1701116A (zh) | 益生细菌:发酵乳杆菌 | |
WO2018155660A1 (ja) | 乳酸菌の死菌体又はその処理物を含有する組成物並びに該組成物を含む化粧品、生活用品、薬剤又は食品 | |
CN1810259A (zh) | 防治龋病的五倍子药物及其提取方法 | |
US20210379121A1 (en) | Probiotics and probiotic compositions having modified carbohydrate metabolism | |
JP4762987B2 (ja) | 乳酸菌培養により得られる血圧低下剤 | |
CN102311932B (zh) | 改善口腔内细菌群的唾液乳酸杆菌及其保健组合物 | |
CN111642746B (zh) | 一种抑制口腔病原菌的食品、口腔清洁及医药组合物 | |
JP5868519B2 (ja) | ロイテリン産生ラクトバチルス・ブレビス | |
CN1391905A (zh) | 一种治疗肠道疾病的微生物制剂 | |
TWI829090B (zh) | 抗憂鬱劑、抗老化劑及抗肥胖劑 | |
CN110279119A (zh) | 混合益生菌那曲4580(Nagqu 4580)在缓解抑郁症的食品中应用 | |
CN1235489C (zh) | 一种复合菌型乳制品及其制备方法 | |
JPWO2012133533A1 (ja) | Qol改善又は持続剤 | |
CN111956546A (zh) | 一种含有玫瑰发酵液的去屑洗发水及其制备方法 | |
KR101101942B1 (ko) | 제과, 제빵 및 제면부산물을 이용한 유산균 미생물제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1073230 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1073230 Country of ref document: HK |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170721 Address after: Japan Tokyo Chengzeng gochome Banqiao District No. 7 9 Patentee after: Lake pond house Address before: Tokyo, Japan Patentee before: Frente Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20070411 Termination date: 20190329 |
|
CF01 | Termination of patent right due to non-payment of annual fee |